Well Lead Medical Co., Ltd. (SHSE:603309) agreed to acquire 19.8% stake in Suzhou Medsure Medical Technology Co., Ltd. from Shenzhen Futian Co-Win Health Industry Investment Fund Partnership Ent. (L.P.) managed by Shenzhen Co-Win Jinxiu Asset Management Limited for CNY12.7 million on December 11, 2021. In similar transaction Well Lead Medical Co., Ltd. (SHSE:603309) agreed to acquire 31.7% from Wang Guangming for CNY 17.7 million. For the year ended December 31, 2021 Suzhou Medsure Medical Technology Co., Ltd. recorded the total assets of CNY 15.4 million, EBIT CNY 3 million, Net loss of CNY 11 million and net assets of CNY -4.6 million. The deal is expected to complete on or before December 15, 2021.